
Please try another search
Formosa Laboratories, Inc., together with its subsidiaries, manufactures and sells active pharmaceutical ingredients (APIs) and ultraviolet absorbers in India, the Netherlands, Japan, Germany, Taiwan, China, Switzerland, the United States, Canada, and internationally. The company offers APIs in the areas of anticancer, vitamin D derivatives, anti-inflammatory and analgesic agents, immunomodulators, respiratory agents, cholesterol and phosphate binders, UV filter, iron deficiency anemia (IDA), CNS agents, MRI enhancing agents, steroids, antibiotics, and other areas; and injectables in the areas of IDA, MRI agents, oncology, and others. It also provides contract development and manufacturing services, including recrystallization, filtration, dialysis, column purification, distillation, spray drying, and micronization; injectable manufacturing and secondary packaging, labeling, and serialization services; custom fermentation services; and peptide synthesis services. In addition, the company offers antibody-drug conjugates services comprising antibody development and manufacture; peptide and polymer drug conjugation; Linker-payload design, synthesis, and manufacturing; bio-conjugation and purification; cytotoxic liquid-filled and lyophilized product from pre-formulation studies to manufacture; and regulatory support. Further, it is involved in chemical trading and investment activities. Formosa Laboratories, Inc. was incorporated in 1985 and is headquartered in Taoyuan, Taiwan.
Name | Age | Since | Title |
---|---|---|---|
Tza-Zen Chaung | - | 2023 | Independent Director |
Yi Mai Hu | - | 2013 | Member of the Supervisory Board |
Zhi Han Zhong | - | 2013 | Director |
Lu Jie Wang | - | 2013 | Director |
Pei Wei Fang | - | 2013 | Member of the Supervisory Board |
Rui An Cai | - | 2013 | Director |
Hong Min Xie | - | 2013 | Director |
Jian Hong Li | - | 2013 | Director |
Zhe Ren Zhuang | - | 2013 | Independent Director |
Wen Ying Yu | - | 2013 | Member of the Supervisory Board |
Ting-Jung Chang | - | 2023 | Independent Director |
Yi-Fen Chen | - | 2022 | Independent Director |
Ta-Jung Lu | - | 2022 | Independent Director |
Chen-Yu Cheng | - | - | Chairman, President & Manager |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review